Pfizer announces positive results from Phase 3 study of 20-valent pneumococcal conjugate vaccine
Pfizer plans to submit an sBLA by the end of this year, subject to discussions with U.S. FDA
Pfizer plans to submit an sBLA by the end of this year, subject to discussions with U.S. FDA
The 562,000 square feet facility has been recognized as the first and largest integrated insulin manufacturer in Malaysia by MBR
With this expansion, the Grand Island site provides redundant capacity to support global supply of media and further extends the site’s capabilities to produce the high-quality technology and materials needed for the development and commercial manufacturing of vaccines and biologic therapies
Sandu Kumarvin is an Ayurvedic digestive and immunity booster for children and also offers several other benefits.
Biopharma and CROs to benefit from simplified access to global research sites
ABDM Hackathon Round 1 – Kickstarting Unified Health Interface (UHI) is being held from 14th to 17th July 2022 as a hybrid event
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
It includes both public and private health facilities including hospitals, clinics, diagnostic laboratories, and imaging centers
Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone
Subscribe To Our Newsletter & Stay Updated